All
Diagnosing GIST: Key Challenges and Treatment Insights
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.
A Survivor and Patient Advocate Reflects on Beating Cancer Twice
Daniel Jernazian, a two-time cancer survivor, shares how sports, advocacy and meeting his idol shaped his journey through illness and recovery.
Celebrating Survival After Transplant: Appreciating My Donor
I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life she helped me keep.
Understanding Therapeutic Options for ER+/HER2- Metastatic Breast Cancer
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
FDA Approves Stoboclo and Osenvelt as Biosimilars Across Some Cancers
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and cancer-related bone conditions.
How CAR T-Cell Therapy Helped This Veteran Beat Cancer Twice
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
What Does It Take to Be Declared Cancer Free After Breast Cancer?
After eleven 11 of survivorship, I’ve been waiting to hear the words, “You’re completely free of cancer! Go in peace,” but I’m wondering if it ever will happen.
Is There a New Standard Way to Treat Advanced-Stage Melanoma?
Ongoing research within the advanced-stage melanoma therapeutic space is beginning to suggest that shorter treatment periods may be sufficient for some.
Embracing Your ‘New Normal’ After a Cancer Diagnosis
Valarie Traynham sat down for an interview in CURE in which she discussed adjusting to life after cancer, detailing her ‘new normal.’
The Emotional Impact of Insurance Delays For Those With Cancer
Dr. Alexandra Zaleta discussed the impact of administrative delays and insurance red tape experienced by patients with advanced cancer.
Dealing With the Unpredictability of Cancer
My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.
Bria-IMT Combo Shows Survival in Phase 2 Breast Cancer Trial
In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.
Screening, Prehab May Reduce Breast Cancer Survivorship Burden
Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after breast cancer treatment.
Body Positivity After a Mastectomy: An Ongoing Quest
It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me accept my new normal.
New Trials Target Brain, Bladder, Ovarian and Other Cancers
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.
Addressing Feelings of Loneliness After a Cancer Diagnosis
Hearing that you have cancer can lead to dark feelings; however, others have walked this road and come out on the other end, a cancer thriver explained.
What You Can’t Do With Cancer: Talking About the Negatives
I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, joy and reasons to keep going.
FDA Approves SIR-Spheres for Liver Cancer Treatment
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both HCC and mCRC.
FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.
Understanding the Risk of Overtreatment in Prostate Cancer
Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.
Empowering the Immune System
TIL therapy is on the rise in melanoma, with potential for other tumor types.
Growing from Embarrassment to Admiration of My Mother’s Breast Cancer
At 12 years of age, I felt embarrassed by my mother’s cancer, but at 47, I see her as the strongest, most beautiful warrior I’ve ever known.
Funding for Cancer Research: Hope in a State of Fear
Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic status.
Healing Through Advocacy and Self-Discovery After AML Diagnosis
Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek connection, and support others through advocacy.
Broken Yet Unbreakable: My Previvor Journey and the Power of Symbolism
Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, and honor my journey with purpose.
My Imaginary Fear of Cancer Recurrence
Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.
How Multidisciplinary Care Impacts Prostate Cancer Treatment
Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.
A New Frontier in Melanoma Treatment
A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) therapy.
Reflections After Nine Years as a Bladder Cancer Survivor
Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.
Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
